PFIZER ROYALTY FREE LICENSE
This AGREEMENT is entered into as of April 1, 1986 by and between PFIZER INC. ("PFIZER"), a Delaware
corporation having an office at 235 East 42nd Street, New York, New York 10017, and ONCOGENE
SCIENCE, INC. ("OSI"), a Delaware corporation having an office at 222 Station Plaza North, Suite 330,
Mineola, New York, 11501.
The parties agree as follows:
The capitalized terms used herein have the meanings specified in Exhibits I, II, III and IV of the Collaborative
Research Agreement dated as of April 1, 1986 between PFIZER and OSI.
2.1. OSI grants to PFIZER a nonexclusive, irrevocable, worldwide, royalty-free, perpetual right and license,
including the right to grant sublicenses, under Joint Patent Rights and Joint Technology to make, have made, use
and sell products in all fields of use except the following:
(a) in vitro and in vivo diagnostics, including in vivo imaging; and
(b) Monoclonal Antibody Technology; and
(c) products sold exclusively for research use.
3.1. PFIZER shall have the right, at its expense, to institute actions under Joint Patent Rights and Joint
Technology for infringement or misappropriation in the fields of use in which OSI has granted rights to PFIZER.
4.1. This Agreement is made and delivered in New York and shall be governed by, and construed in accordance
with, the laws of the State of New York applicable to agreements made and to be performed entirely within the
State of New York.
4.2. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective legal
representatives, successors and assigns.
ONCOGENE SCIENCE, INC.
By: /s/ John R. Stephens
Title: Scientific Director
By: /s/ Barry M. Bloom
3.1. PFIZER shall have the right, at its expense, to institute actions under Joint Patent Rights and Jo